Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Invivoscribe Submits Biomarker Test for Astellas Cancer Drug to China's NMPA

publication date: May 12, 2020

Invivoscribe, a San Diego precision medicine company, has submitted its FLT3 mutation assay to China's NMPA as part of Astellas' NDA for Xospata® (gilteritinib), a treatment for acute myeloid leukemia. Invivoscribe developed the LeukoStrat CDx FLT3 Mutation Assay as a companion diagnostic supporting use of gilteritinib to treat adult patients with relapsed/refractory FLT3-mutated AML. The assay is approved in the US, the EU, Australia and Japan. Invivoscribe has also opened a Shanghai lab to provide laboratory testing services for clinical trials and pharmaceutical partners. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here